Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
Examining Optimal Dosage for Heart Failure Drug
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
Investigating How Cholera Bacteria Toxins Inhibit Autophagy
A new Northwestern Medicine study highlighted for the first time how a toxin from the extracellular bacterium Vibrio cholerae can inhibit autophagy and endosomal trafficking.